TRT 'feel fuller post-show' claims: what the data actually says
Quick answer
Testosterone replacement therapy is FDA-approved for diagnosed hypogonadism, typically targeting serum testosterone of 400-700 ng/dL with doses of 50-100mg per week under physician supervision. Bodybuilding cruise protocols frequently exceed these doses, producing supraphysiologic testosterone levels that fall outside the clinical definition of replacement. Post-competition hormonal suppression is a documented and serious physiological event that warrants medical evaluation, not self-managed hormone protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Two weeks after a bodybuilding competition, @jose_physique is describing feeling "fuller and healthier" on what he's calling a TRT dose. Post-show recovery content is a well-worn genre in bodybuilding TikTok, and the implicit argument here is familiar: returning to a testosterone replacement dose after the extremes of contest prep restores the body to a better baseline. The framing of "TRT dose" after a competitive cycle is doing a lot of work. In bodybuilding contexts, that phrase often describes 100-200mg of testosterone per week used as a cruise between blasts, which is categorically different from the 50-100mg per week typically used in medically supervised hypogonadism treatment. The hashtags confirm this is bodybuilding content, not a clinical discussion. The "fuller" language almost certainly refers to muscle glycogen and intramuscular water replenishment after the extreme caloric and water restriction that precedes competition day.
What does the science actually show?
Post-competition physiology is genuinely harsh. Research by Rossow et al. (2013, International Journal of Sports Physiology and Performance) documented a natural male competitor whose testosterone dropped to 55 ng/dL by contest day, well into hypogonadal range, with mood disturbances and metabolic disruption persisting for months afterward. Glycogen supercompensation following severe carbohydrate restriction is real and well-documented: Bergstrom and Hultman (1967, Nature) showed skeletal muscle can overshoot baseline glycogen stores by 50-100% during refeeding. This explains the visual fullness. What exogenous testosterone contributes specifically to that sensation, versus simply eating more carbohydrates and calories after a deficit, is genuinely hard to separate. Testosterone does stimulate glycogen synthase activity and IGF-1 production, but the caloric context matters enormously. A 2021 review in Endocrine Reviews by Basaria confirmed testosterone's anabolic role, but doses studied clinically were far below typical bodybuilding cruise doses.
Where does the social media noise diverge from clinical reality?
The biggest problem with "TRT dose" framing in bodybuilding content is that it borrows clinical legitimacy for a practice that sits well outside clinical medicine. Actual TRT for diagnosed hypogonadism targets serum testosterone in the 400-700 ng/dL range using doses typically between 50-100mg of testosterone cypionate or enanthate weekly, per Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). Bodybuilding "cruise" doses of 150-200mg weekly can push total testosterone to 1,000-1,500 ng/dL or higher, which is not replacement, it is supraphysiologic use. Calling it TRT on a platform with 6,000+ viewers, many of whom may be curious about hormone therapy for legitimate reasons, conflates two very different practices. The "healthy" framing is also worth scrutinizing. Post-show rebounds involve real hormonal disruption, and adding exogenous testosterone suppresses the HPGA, meaning natural recovery is not happening.
What should you actually know?
If you are watching this as someone exploring TRT for actual hypogonadism symptoms, low energy, reduced libido, poor body composition despite reasonable lifestyle habits, this video is not a useful reference point. Competitive bodybuilders who use supraphysiologic androgens during a season and then cruise on "TRT doses" have a fundamentally different hormonal situation than someone with primary or secondary hypogonadism who has never used exogenous hormones. The "fuller and healthier" outcome is likely a combination of caloric refeeding, glycogen restoration, reduced cortisol from ending extreme contest prep, and possibly the direct anabolic effects of testosterone. Any licensed TRT provider should be evaluating total testosterone, free testosterone, LH, FSH, estradiol, hematocrit, and PSA before and during treatment. The feel-good post-show video format is not a substitute for that workup, and treating it as one is where people get into trouble.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT 'feel fuller post-show' claims: what the data actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT 'feel fuller post-show' claims: what the data actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy is FDA-approved for diagnosed hypogonadism, typically targeting serum testosterone of 400-700 ng/dL with doses of 50-100mg per week under physician supervision.
FormBlends verdict
Testosterone replacement therapy is FDA-approved for diagnosed hypogonadism, typically targeting serum testosterone of 400-700 ng/dL with doses of 50-100mg per week under physician supervision. Bodybuilding cruise protocols frequently exceed these doses, producing supraphysiologic testosterone levels that fall outside the clinical definition of replacement. Post-competition hormonal suppression is a documented and serious physiological event that warrants medical evaluation, not self-managed hormone protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy is FDA-approved for diagnosed hypogonadism, typically targeting serum testosterone of 400-700 ng/dL with doses of 50-100mg per week under physician supervision. Bodybuilding cruise protocols frequently exceed these doses, producing supraphysiologic testosterone levels that fall outside the clinical definition of replacement. Post-competition hormonal suppression is a documented and serious physiological event that warrants medical evaluation, not self-managed hormone protocols.
- Actual medical TRT targets serum testosterone of 400-700 ng/dL using 50-100mg per week, per Endocrine Society guidelines (Bhasin et al., 2018).
- Bodybuilding cruise doses of 150-200mg weekly can produce testosterone levels of 1,000-1,500 ng/dL or higher, which is supraphysiologic, not replacement.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Actual medical TRT targets serum testosterone of 400-700 ng/dL using 50-100mg per week, per Endocrine Society guidelines (Bhasin et al., 2018).
- Bodybuilding cruise doses of 150-200mg weekly can produce testosterone levels of 1,000-1,500 ng/dL or higher, which is supraphysiologic, not replacement.
- Post-competition muscle fullness is largely driven by glycogen supercompensation during caloric refeeding, not specifically by testosterone administration.
- Rossow et al. (2013) documented testosterone levels as low as 55 ng/dL in competitive bodybuilders by contest day, reflecting severe HPGA suppression.
- Exogenous testosterone at any dose suppresses LH and FSH, blocking natural endocrine recovery after a competitive cycle.
- Anyone pursuing TRT for legitimate hypogonadism symptoms should have total testosterone, free testosterone, LH, FSH, estradiol, hematocrit, and PSA evaluated before starting treatment.
- Bodybuilding post-show recovery content is not a clinical reference for TRT candidates with diagnosed hypogonadism.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jose Marin | Online Coach · TikTok creator
6.2K views on this video
2 weeks post show feeling way fuller and healthy on trt dose #fyp #bodybuilding
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Jose Marin | Online Coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.